By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > TriplePoint Venture Growth: I’m Skipping The 15.2% Dividend Yield In 2024 (NYSE:TPVG)
News

TriplePoint Venture Growth: I’m Skipping The 15.2% Dividend Yield In 2024 (NYSE:TPVG)

News
Last updated: 2023/12/04 at 2:57 AM
By News
Share
6 Min Read
SHARE

Contents
Investment Income And Net Asset ValueUnderwriting Quality And Payment-In-Kind

Venture capital-focused business development company TriplePoint Venture Growth (NYSE:TPVG) is likely set to eke out positive total returns for 2023 even after its common shares have fallen 17% over the last 1 year. The BDC’s most recent quarterly cash dividend distribution at $0.40 per share was unchanged sequentially for what currently works out to be a 15.2% annualized forward dividend yield. The BDC also had a spillover income of $1.03 per share at the end of its fiscal 2023 third quarter, enough to cover 2.6x quarters of its base dividend. Hence, the current yield is extremely secure but like other BDCs faces the end of the Fed rate hiking cycle. CME’s 30-Day Fed Funds futures pricing data is currently pricing in a 55% chance that the 20 March 2024 FOMC meeting will see the first 25 basis points cut to a Fed funds rate currently sitting at a 22-year high of 5.25% to 5.50%.

FOMC rate move probability

CME FedWatch Tool

Whilst the pace and intensity of cuts will drive how material of a headwind the dovish pivot is for all BDCs, tickers operating with higher leverage and a high degree of credit on non-accrual status will see the risk posed by this heightened. TPVG reported a debt-to-equity ratio of 1.6x as of the end of its third quarter, higher than other venture debt-focused BDCs like Hercules Capital (HTGC) and Horizon Technology Finance (HRZN). TPVG holds the highest ratio of its peers.

Chart
Data by YCharts

Critically, the collapse of Silicon Valley Bank has opened up a significant opportunity for non-bank players in the venture debt market as the regional bank was the biggest player in the space. SVB provided 50% of all venture loans in the past 20 years. Its collapse has left a substantial gap for BDCs like TPVG to fill with short maturity and highly secured loans to startups who typically don’t want to give up equity. Coupons are typically higher than other BDCs due to the higher credit risk of startup borrowers. I last covered the BDC in the summer when bad loans were spiking to form a trend that’s yet to be reversed.

Investment Income And Net Asset Value

TriplePoint Venture Growth Fiscal 2023 Third Quarter Income Statement

TriplePoint Venture Growth Fiscal 2023 Third Quarter Form 10-Q

TPVG reported a total investment income of $35.74 million for its third quarter, up 20.3% over its year-ago comp and a beat by $2.03 million on analyst consensus. Net investment income grew by 13% year-over-year with NII per share of $0.54, up 3 cents from its year-ago figure. Hence, TPVG is significantly outearning its base dividend distribution by around $0.14 per share, a 74% payout ratio. This beat consensus by around 4 cents and meant the continued buildup of spillover income. There will not be a hike to the base dividend though with management stressing during the third-quarter earnings call that see the current base distribution as solid and that they intend to defend NAV and reduce their high leverage ratio.

Chart
Data by YCharts

NAV came in at $374 million at the end of the third quarter, around $10.37 per share, down by around 33 cents sequentially. It was also down by a material $2.32 from $12.69 per share in the year-ago period. TPVG has seen its NAV per share decline for 7 consecutive quarters, peaking at $14.01 in the fourth quarter of its fiscal 2021. The decline looks less pronounced on a nominal basis but the BDC has expanded its share count by 45% over the last 5 years. The issuance of new equity by BDCs is not controversial if completed above NAV and TPVG has traded above NAV for most of the last 5 years. However, an expansion of shares that leads to a still high leverage ratio and an erosion of NAV per share is not great for shareholders.

Chart
Data by YCharts

Underwriting Quality And Payment-In-Kind

TriplePoint Venture Growth Fiscal 2023 Third Quarter Credit Performance

TriplePoint Venture Growth Fiscal 2023 Third Quarter Presentation

The BDC has faced headwinds from credit quality. Net losses on its investments came in at $25.56 million during the third quarter. There were also eight portfolio companies on non-accrual status with an aggregate cost and fair value of $94.8 million and $39.2 million respectively. As TPVG’s debt portfolio at fair value was $782.9 million at the end of the third quarter, non-accruals at fair value was 5%, up from 0.98% in the year-ago comp. To be clear, a year ago TPVG had one portfolio company on non-accrual status with a fair value of $8.4 million. This was against a $856.7 million debt portfolio at fair value. Portfolio companies rated yellow to red at 13.7% during the third quarter was a 370 basis points increase from a year ago and a 180 basis points increase sequentially. Payment-in-kind income at $3.27 million, 9.14% of total investment income, was also up from a year-ago figure of $1.66 million. This was around 5.59% of total investment income in the year-ago period. Hence, whilst the substantial dividend yield is safe and a year-end special looks likely, credit quality headwinds mean it is hard to recommend this as a buy.

Read the full article here

News December 4, 2023 December 4, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)

By News
News

Webster Financial Stock: A Bit More Upside Is Warranted (NYSE:WBS)

By News
News

Zoom Stock: 30% Net Cash Position More Important Amidst Market Volatility (NASDAQ:ZM)

By News
News

EIDO: This Indonesian ETF Is A Very Poor Choice For Long-Term Oriented Investors (NYSEARCA:EIDO)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?